Advertisement

Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease

      Abstract

      Objective

      We evaluated the temporal association between arterial stiffening and the early stage of renal functional decline.

      Methods

      In 2053 Japanese employees with an estimated glomerular filtration rate (GFR) of ≥60 ml/min/1.73 m2 plus no proteinuria (40 ± 8 years old) at the start, brachial-ankle pulse wave velocity (baPWV) and serum C-reactive protein (CRP) were measured before and after a 5–6-year follow-up period.

      Results

      After adjusting for confounding variables including serum CRP levels, higher baseline baPWV was associated with lower follow-up GFR (value expressed as per doubling: −16; 95% confidence interval: −24 to −9; P < 0.01) and with higher annual rate of decline in GFR (value expressed as per doubling: −3; 95% confidence interval: −4 to −2; P < 0.01). Every m/s higher baPWV was associated with a 36% increased odds (95% CI 1.09–1.70; P < 0.01) for a development of a GFR <60 ml/min/1.73 m2 at follow-up. In contrast, baseline GFR was not associated with follow-up baPWV (P = 0.08) or the annual rate of change in baPWV (P = 0.11).

      Conclusion

      In a Japanese occupational cohort with normal renal function/early chronic kidney disease, elevated arterial stiffness was an independent risk factor for the decline in renal function. CRP did not appear to exert any significant influence on this association.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brosius III, F.C.
        • Hostetter T.H.
        • Kelepouris E.
        • et al.
        American Heart Association Kidney and Cardiovascular Disease Council, Council on High Blood Pressure Research, Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Quality of Care and Outcomes Research Interdisciplinary Working Group: Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group—Developed in collaboration with the National Kidney Foundation.
        Circulation. 2006; 114: 1083-1087
        • Gusbeth-Tatomir P.
        • Covic A.
        Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
        Kidney Blood Press Res. 2007; 30: 97-107
        • Taal M.W.
        • Brenner B.M.
        Predicting initiation and progression of chronic kidney disease: developing renal risk scores.
        Kidney Int. 2006; 70: 1694-1705
        • Jaar B.G.
        • Khatib R.
        • Plantinga L.
        • Boulware L.E.
        • Powe N.R.
        Principles of screening for chronic kidney disease.
        Clin J Am Soc Nephrol. 2008; 3: 601-609
        • O’Rourke M.F.
        • Safar M.E.
        Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy.
        Hypertension. 2005; 46: 200-204
        • Lehoux S.
        • Tegui A.
        Mechanical stress and the arterial wall.
        in: Safar M. O’Rourke M. Arterial stiffness in hypertension. Elsevier, 2006: 75-98
        • Yamashina A.
        • Tomiyama H.
        • Takeda K.
        • et al.
        Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement.
        Hypertens Res. 2002; 25: 359-364
        • Tanaka H.
        • Munakata M.
        • Kawano Y.
        • et al.
        Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness.
        J Hypertens. 2009; 27: 2022-2027
        • Tomiyama H.
        • Koji Y.
        • Yambe M.
        • et al.
        Brachial – ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome.
        Circ J. 2005; 69: 815-822
        • Tomiyama H.
        • Hashimoto H.
        • Hirayama Y.
        • et al.
        Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose.
        Hypertension. 2006; 47: 180-188
        • Hata Y.
        • Mabuchi H.
        • Saito Y.
        • et al.
        Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
        J Atheroscler Thromb. 2002; 9: 1-27
        • Teramoto T.
        • Sasaki J.
        • Ueshima H.
        • et al.
        Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
        J Atheroscler Thromb. 2007; 14: 45-50
        • Japan Diabetes Society
        Guidelines for diagnosis of diabetes mellitus.
        J Jpn Diabetes Soc. 1999; 42 (in Japanese): 385-404
      1. Japanese Society of Hypertension. Guidelines for the management of hypertension 2004:7–34 (in Japanese).

        • Sin D.D.
        • Man S.F.
        Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.
        Circulation. 2003; 107: 1514-1519
        • Ix J.H.
        • Katz R.
        • De Boer I.H.
        • et al.
        Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).
        J Am Coll Cardiol. 2009; 54: 1176-1184
        • Matsuo S.
        • Imai E.
        • Horio M.
        • et al.
        Revised equations for estimated GFR from serum creatinine in Japan.
        Am J Kidney Dis. 2009; 53: 982-992
        • Matsumoto C.
        • Tomiyama H.
        • Yamada J.
        • et al.
        Association of blood pressure levels with the effects of alcohol intake on the vasculature in Japanese men.
        Hypertens Res. 2009; 32: 127-132
        • Stevens L.A.
        • Coresh J.
        • Greene T.
        • Levey A.S.
        Assessing kidney function – measured and estimated glomerular filtration rate.
        N Engl J Med. 2006; 354: 2473-2483
        • Ankle Brachial Index Collaboration
        • Fowkes F.G.
        • Murray G.D.
        • et al.
        Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.
        JAMA. 2008; 300: 197-208
        • Gosse P.
        • Coulon P.
        • Papaioannou G.
        • et al.
        Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive.
        J Hypertens. 2009; 27: 1303-1308
        • Ohya Y.
        • Iseki K.
        • Iseki C.
        • et al.
        Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort.
        Am J Kidney Dis. 2006; 47: 790-797
        • Madero M.
        • Wassel C.L.
        • Peralta C.A.
        • et al.
        Cystatin C Associates with arterial stiffness in older adults.
        J Am Soc Nephrol. 2009; 20: 1086-1093
        • Upadhyay A.
        • Hwang S.J.
        • Mitchell G.F.
        • et al.
        Arterial Stiffness in Mild-to-Moderate CKD.
        J Am Soc Nephrol. 2009; 20: 2044-2053
        • Benetos A.
        • Adamopoulos C.
        • Bureau J.M.
        • et al.
        Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period.
        Circulation. 2002; 105: 1202-1207
        • Silverstein D.M.
        Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.
        Pediatr Nephrol. 2009; 24: 1445-1452
        • Stuveling E.M.
        • Hillege H.L.
        • Bakker S.J.
        • et al.
        C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
        Kidney Int. 2003; 63: 654-661
        • Shlipak M.G.
        • Katz R.
        • Sarnak M.J.
        • et al.
        Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
        Ann Intern Med. 2006; 145: 237-246
        • Barnett A.H.
        • Bain S.C.
        • Bouter P.
        • et al.
        Diabetics exposed to telmisartan and enalapril study group: angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
        N Engl J Med. 2004; 351: 1952-1961